Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer
N Engl J Med
.
2023 Oct 19;389(16):1534.
doi: 10.1056/NEJMc2310641.
Authors
Saurav Verma
1
,
Mark Vincent
1
,
Daniel Breadner
1
Affiliation
1
London Regional Cancer Program, London, ON, Canada daniel.breadner@lhsc.on.ca.
PMID:
37851885
DOI:
10.1056/NEJMc2310641
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / surgery
Docetaxel / therapeutic use
Humans
Lung Neoplasms* / drug therapy
Lung Neoplasms* / surgery
Nivolumab / therapeutic use
Substances
Nivolumab
Docetaxel